Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Vaccine|February 26, 2023
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452Eline A Feitsma, Yester F Janssen, Hendrikus H Boersma, et al.
Langenbeck'S Archives of Surgery|January 8, 2025
Establishing reference curves for vital tissue perfusion using quantitative near-infrared fluorescence imaging with indocyanine greenFloris P Tange, Roderick C Peul, Pim van den Hoven, et al.
Langenbeck'S Archives of Surgery|March 26, 2016
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cmLutske Lodewijk, Wouter P Kluijfhout, Jakob W Kist, et al.
JAMA Surgery|February 28, 2019
Clinical Outcomes After Unilateral Adrenalectomy for Primary AldosteronismWessel M C M Vorselaars, Sjoerd Nell, Emily L Postma, et al.
The British Journal of Surgery|February 22, 2023
Impact of the COVID-19 pandemic on surgical care in the NetherlandsMichelle R de Graaff, Rianne N M Hogenbirk, Yester F Janssen, et al.
Journal of the American College of Surgeons|December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched AnalysisKristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
Cancer|April 7, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, et al.
Annals of Surgery|February 7, 2022
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral CentersKristy K Broman, Tasha M Hughes, Brooke C Bredbeck, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
BMC Cancer|April 27, 2019
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P Rovers, Checca Bakkers, Geert A A M Simkens, et al.
Pageof 14